433 related articles for article (PubMed ID: 2964362)
1. Properties of [3H]1-desamino-8-D-arginine vasopressin as a radioligand for vasopressin V2-receptors in rat kidney.
Marchingo AJ; Abrahams JM; Woodcock EA; Smith AI; Mendelsohn FA; Johnston CI
Endocrinology; 1988 Apr; 122(4):1328-36. PubMed ID: 2964362
[TBL] [Abstract][Full Text] [Related]
2. Localization of vasopressin binding sites in rat tissues using specific V1 and V2 selective ligands.
Phillips PA; Abrahams JM; Kelly JM; Mooser V; Trinder D; Johnston CI
Endocrinology; 1990 Mar; 126(3):1478-84. PubMed ID: 2307115
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of arginine vasopressin receptors in the rat testis.
Meidan R; Hsueh AJ
Endocrinology; 1985 Jan; 116(1):416-23. PubMed ID: 2981073
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a specific, high affinity [3H]arginine8 vasopressin-binding site on liver microsomes from different strains of rat and the role of magnesium.
Gopalakrishnan V; Triggle CR; Sulakhe PV; McNeill JR
Endocrinology; 1986 Mar; 118(3):990-7. PubMed ID: 3004905
[TBL] [Abstract][Full Text] [Related]
5. V2-like vasopressin receptor mobilizes intracellular Ca2+ in rat medullary collecting tubules.
Champigneulle A; Siga E; Vassent G; Imbert-Teboul M
Am J Physiol; 1993 Jul; 265(1 Pt 2):F35-45. PubMed ID: 8342613
[TBL] [Abstract][Full Text] [Related]
6. [3H]desGly-NH2(9)-d(CH2)5[D-Ileu2,Ileu4]AVP: an AVP V2 receptor antagonist radioligand.
Trinder D; Stephenson JM; Gao X; Phillips PA; Risvanis J; Johnston CI
Peptides; 1991; 12(6):1195-200. PubMed ID: 1815207
[TBL] [Abstract][Full Text] [Related]
7. Autoradiographic localization of vasopressin and oxytocin binding sites in rat kidney.
Tribollet E; Barberis C; Dreifuss JJ; Jard S
Kidney Int; 1988 May; 33(5):959-65. PubMed ID: 3392884
[TBL] [Abstract][Full Text] [Related]
8. Localization and quantification of nonapeptide binding sites in the kidney of Xenopus laevis: evidence for the existence of two different nonapeptide receptors.
Kloas W; Hanke W
Gen Comp Endocrinol; 1992 Jan; 85(1):71-8. PubMed ID: 1563620
[TBL] [Abstract][Full Text] [Related]
9. V2 receptor antagonism of DDAVP-induced release of hemostasis factors in conscious dogs.
Bernat A; Hoffmann P; Dumas A; Serradeil-le Gal C; Raufaste D; Herbert JM
J Pharmacol Exp Ther; 1997 Aug; 282(2):597-602. PubMed ID: 9262320
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of a vasopressin isoreceptor in porcine seminal vesicles.
Maggi M; Kassis S; Malozowski S; Guardabasso V; Rodbard D
Proc Natl Acad Sci U S A; 1986 Dec; 83(23):8824-8. PubMed ID: 2947237
[TBL] [Abstract][Full Text] [Related]
11. Binding properties of a selective tritiated vasopressin V2 receptor antagonist, [H]-SR 121463.
Serradeil-Le Gal C; Raufaste D; Double-Cazanave E; Guillon G; Garcia C; Pascal M; Maffrand JP
Kidney Int; 2000 Oct; 58(4):1613-22. PubMed ID: 11012895
[TBL] [Abstract][Full Text] [Related]
12. Vasopressin receptors in rat brain and kidney: studies using a radio-iodinated V1 receptor antagonist.
Phillips PA; Kelly JM; Abrahams JM; Grzonka Z; Paxinos G; Mendelsohn FA; Johnston CI
J Hypertens Suppl; 1988 Dec; 6(4):S550-3. PubMed ID: 2977179
[TBL] [Abstract][Full Text] [Related]
13. Hepatic vasopressin receptor: differential effects of divalent cations, guanine nucleotides, and N-ethylmaleimide on agonist and antagonist interactions with the V1 subtype receptor.
Gopalakrishnan V; McNeill JR; Sulakhe PV; Triggle CR
Endocrinology; 1988 Aug; 123(2):922-31. PubMed ID: 2969327
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of V1a vasopressin receptors in the rat cortical collecting duct.
Ammar A; Roseau S; Butlen D
Am J Physiol; 1992 Apr; 262(4 Pt 2):F546-53. PubMed ID: 1533099
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of two classes of receptors for oxytocin and vasopressin in porcine tunica albuginea, epididymis, and vas deferens.
Maggi M; Malozowski S; Kassis S; Guardabasso V; Rodbard D
Endocrinology; 1987 Mar; 120(3):986-94. PubMed ID: 3026794
[TBL] [Abstract][Full Text] [Related]
16. [125I]-[d(CH2)5, Sar7]AVP: a selective radioligand for V1 vasopressin receptors.
Kelly JM; Abrahams JM; Phillips PA; Mendelsohn FA; Grzonka Z; Johnston CI
J Recept Res; 1989; 9(1):27-41. PubMed ID: 2521670
[TBL] [Abstract][Full Text] [Related]
17. Vasopressin V2 receptor binding is down-regulated during renal escape from vasopressin-induced antidiuresis.
Tian Y; Sandberg K; Murase T; Baker EA; Speth RC; Verbalis JG
Endocrinology; 2000 Jan; 141(1):307-14. PubMed ID: 10614652
[TBL] [Abstract][Full Text] [Related]
18. Interaction of a vasopressin antagonist with vasopressin receptors in the septum of the rat brain.
Dorsa DM; Brot MD; Shewey LM; Meyers KM; Szot P; Miller MA
Synapse; 1988; 2(3):205-11. PubMed ID: 2975069
[TBL] [Abstract][Full Text] [Related]
19. Arginine vasopressin increases intracellular calcium ion concentration in isolated mouse collecting tubule cells: distinct mechanism of action through V2 receptor, but independent of adenylate cyclase activation.
Naruse M
Nihon Jinzo Gakkai Shi; 1992 Apr; 34(4):337-47. PubMed ID: 1635278
[TBL] [Abstract][Full Text] [Related]
20. [3H]AVP binding to rat renal tubular receptors during long-term treatment with an antagonist of arginine vasopressin.
Mah SC; Whitebread SE; De Gasparo M; Hofbauer KG
Peptides; 1988; 9(3):595-600. PubMed ID: 3420014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
